VDC
ELV icon

Van Diest Capital’s Elevance Health ELV Stock Holding History

Van Diest Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$670K Sell
1,733
-2,655
-61% -$985K 0.6% 42
2026
Q1 		$1.28M Buy
4,388
+3,039
+225% +$999K 1.01% 21
2025
Q4 		$473K Buy
+1,349
New +$456K 0.71% 38

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Van Diest Capital's ELV Position: Q2 2026 in Review

Van Diest Capital reduced its Elevance Health (ELV) stake by 61% in Q2 2026, selling an estimated $985K and leaving 1,733 shares worth $670K. The position accounts for 0.6% of the portfolio, ranked #42.

Van Diest Capital first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.28M in Q1 2026. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Van Diest Capital held 1,733 shares of Elevance Health worth $670K as of Q2 2026.
  • Van Diest Capital sold 2,655 Elevance Health shares in Q2 2026, an estimated $985K.
  • Elevance Health made up 0.6% of Van Diest Capital's portfolio in Q2 2026, its #42 holding.
  • Van Diest Capital first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • Van Diest Capital's Elevance Health position peaked at $1.28M in Q1 2026.
  • 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Van Diest Capital's 13F filing for Q2 2026, filed 4 Aug 2026.